1. Home
  2. HALO vs KLAR Comparison

HALO vs KLAR Comparison

Compare HALO & KLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$61.63

Market Cap

8.8B

Sector

Health Care

ML Signal

HOLD

KLAR

Klarna Group plc Ordinary Shares

N/A

Current Price

$12.35

Market Cap

9.1B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
KLAR
Founded
1998
2005
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
9.1B
IPO Year
2001
N/A

Fundamental Metrics

Financial Performance
Metric
HALO
KLAR
Price
$61.63
$12.35
Analyst Decision
Buy
Buy
Analyst Count
11
15
Target Price
$78.18
$39.57
AVG Volume (30 Days)
1.3M
6.2M
Earning Date
05-05-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.56
N/A
Revenue
$151,862,000.00
N/A
Revenue This Year
$28.24
$28.78
Revenue Next Year
$12.79
$19.96
P/E Ratio
$24.74
N/A
Revenue Growth
N/A
N/A
52 Week Low
$47.50
$12.50
52 Week High
$82.22
$47.48

Technical Indicators

Market Signals
Indicator
HALO
KLAR
Relative Strength Index (RSI) 30.59 34.71
Support Level $61.23 N/A
Resistance Level $65.40 $16.78
Average True Range (ATR) 1.54 0.98
MACD -0.06 0.16
Stochastic Oscillator 1.27 4.13

Price Performance

Historical Comparison
HALO
KLAR

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About KLAR Klarna Group plc Ordinary Shares

Klarna is the largest pure-play in the buy now, pay later space. The company operates a two-sided network with a payment method at its core, but it is ultimately a lender. Merchants sign up with Klarna to increase turnover in their stores. Primarily, Klarna can provide merchants with higher conversion rates and average order values relative to other payment methods. Some merchants enter a symbiotic relationship with Klarna, advertising its brand on the product page to drive conversion and to benefit from Klarna's brand value in the merchant's sales funnel. Customers use Klarna for its ease of use, quick access to credit, zero-interest financing, and lower reminder fees.

Share on Social Networks: